Antipyretic therapy reduces overheating during exercise in people with MS, reveals study

A recent study published in the Journal of Neurology found that antipyretic (fever-reducing) treatments before exercise can significantly reduce the risk of overheating, a common deterrent to physical activity in people with multiple sclerosis (pwMS). This research opens new avenues for to manage MS symptoms and enhance exercise participation among pwMS.

Multiple sclerosis is a chronic condition that affects the central nervous system and often leads to sensitivity to heat in many individuals, which in turn makes exercise and physical activity a challenge due to the risk of overheating. However, regular exercise is crucial for pwMS which offers benefits such as improved strength, mood and overall quality of life. The study explored the effectiveness of pre-exercise antipyretic treatment in managing body temperature and enhancing exercise tolerance to address the challenge of heat sensitivity.

This randomized controlled trial involved adults over the age of 18 diagnosed with relapsing-remitting MS, who reported heat sensitivity during exercise. The participants were randomly assigned to one of six sequences, and were subjected to receive doses of either aspirin, acetaminophen or a placebo before undertaking a maximal exercise test. The primary outcomes measured were changes in body temperature and total time to exhaustion (TTE), with secondary outcomes focusing on physiological and patient-reported outcomes (PROs).

The results showed a significant reduction in body temperature increases after administering aspirin and acetaminophen when compared to placebo. Aspirin led to a negligible increase in body temperature, while acetaminophen showed a modest increase, both significantly lower than the placebo group. The treatments did not significantly affect TTE during the exercise tests which suggests that while antipyretic medications can effectively manage body temperature, they do not necessarily extend exercise duration in a maximal exercise setting.

Also, aspirin demonstrated benefits across all secondary outcomes including physiological markers of exercise productivity and PROs related to fatigue, pain and perceived exertion when compared to placebo. Acetaminophen also showed consistent benefits that highlights the potential of these common medications to enhance exercise experiences for pwMS. Overall, the research offers a practical solution to one of the significant barriers to physical activity underwent by individuals with MS by demonstrating that antipyretic treatments can reduce overheating during exercise.

References:

Leavitt, V. M., Tozlu, C., Nelson, K. E., Boehme, A. K., Donnelly, J. E., Aguerre, I., Spinner, M., Riley, C. S., Stein, J., & Onomichi, K. (2024). A randomized controlled trial of oral antipyretic treatment to reduce overheating during exercise in adults with multiple sclerosis. In Journal of Neurology. Springer Science and Business Media LLC. https://doi.org/10.1007/s00415-023-12147-6

Powered by WPeMatico

20% urea cream may effectively manage patients with keratosis pilaris Study

20% urea cream may effectively manage patients with keratosis pilaris suggests a new study published in the Journal of Drugs in Dermatology.

Keratosis pilaris (KP) is a benign dermatosis consisting of folliculocentric keratotic papules or pustules with surrounding erythema, often on proximal extensor surfaces of extremities. Management strategies for Keratosis pilaris largely center on moisturization and exfoliation. Urea, a well-established ingredient in topical skincare, is a component of the natural moisturizing factors with concentration-dependent humectant, emollient, and exfoliative properties. Given the overlap of urea’s properties and management goals of Keratosis pilaris, a 4-week, open-label, noncomparative clinical study was conducted to evaluate a moisturizing cream formulated with 20% urea for use in Keratosis pilaris. Thirty participants aged 18 to 65 years with Keratosis pilaris completed this study. After a 5-day washout period, study participants applied a 20% urea cream once daily to areas of Keratosis pilaris for 4 weeks. At baseline, 1-week, and 4-week visits, clinical grading of skin texture, adverse event monitoring, and participant satisfaction questionnaires were conducted. After 1 week and 4 weeks of product use, the percent change in skin smoothness/texture from baseline was significant (P≤0.001). Furthermore, after 4 weeks of use, the majority of participants indicated satisfaction with the feel of their skin, as well as improved confidence and decreased embarrassment related to their skin. No significant adverse events were reported. Overall, the results of this study support that 20% urea cream is generally well tolerated and suitable for use in treating Keratosis pilaris.

Reference:

McCormick E, Nussbaum D, Friedman A, Pham H, Meckfessel MH, Emesiani C. Evaluation of a Moisturizing Cream with 20% Urea for Keratosis Pilaris. J Drugs Dermatol. 2024 Jan 1;23(1):1274-1277. doi: 10.36849/JDD.7806. PMID: 38206153.

Keywords:

20% urea cream, keratosis pilaris, McCormick E, Nussbaum D, Friedman A, Pham H, Meckfessel MH, Emesiani C

Powered by WPeMatico

Negligence in laparoscopic cholecystectomy leading to death: NCDRC slaps Rs 40 Lakh Compensation on hospital, surgeon

New Delhi: The National Consumer Disputes Redressal Commission (NCDRC) recently upheld the order of the State Commission which had held a Patiala-based hospital and its surgeon liable for negligence and deficiency in service while performing laparoscopic cholecystectomy.

During the surgery, the patient suffered a cut injury to the portal vein, requiring the conversion of laparoscopic surgery to an open procedure. However, the condition of the patient worsened leading to her death.

While considering the plea by the doctor and hospital, the Apex Consumer Court upheld the order of the State Commission directing the doctor and hospital to pay Rs 40 lakh as compensation to the husband and the children of the deceased.

The matter goes back to 2014 when the main complainant’s wife approached Janak Surgicare Hospital where after examining the patient, the treating doctor Dr. Arora diagnosed her with Ch. Cholecystitis and Cholelithiasis. The doctor recommended laparoscopic Chole/Open Chole and certain biochemistry tests and abdominal ultrasound. 

An ultrasound of her abdomen revealed 5 mm multiple stones in the gallbladder. Later, the patient was admitted to the treating hospital in Patiala and a laparoscopic cholecystectomy was scheduled. The procedure was performed by the treating hospital’s Dr Arora with assistance from Dr. Kapoor. It was alleged that during the surgery, she suffered a cut injury to the portal vein, requiring the conversion of laparoscopic surgery to an open procedure. Portal vein injury resulted in leakage of blood into her abdominal cavity, leading to severe deterioration in her condition.

However, due to lack of facilities, she was taken in an ambulance to PGI Chandigarh for vascular repair, accompanied by two OT assistants. In transit, her condition worsened, prompting a decision to admit her to Fortis Hospital, Mohali where a vascular surgeon performed surgery to rectify the portal vein injury. Allegedly, due to a delay in vascular repair and significant blood loss, the patient died.

Additionally, the treating hospital and the doctor allegedly erroneously communicated that no vascular surgeon was accessible in Patiala. Contrary to this, they contended that such facilities were available at a hospital in Patiala. The complainants alleged that the hospital and the doctor were negligent in not referring the patient to the Patiala-based hospital or engaging a doctor from the said hospital.

Further, they alleged that the negligence by the treating doctor and hospital during the surgery resulted in the occurrence of the portal vein injury, which was allegedly acknowledged by the treating facility before the Medical Board. Therefore, filing a consumer complaint, the complainants demanded Rs 50 lakh as compensation and other reliefs.

Responding to this, the doctor and the hospital objected to the complaint stating that the complaint is not maintainable. They contended that there was no negligence in the treatment. Emphasizing the qualifications and competence of their staff, they asserted possessing the necessary skill and experience, and that the duties were performed diligently with the assistance of competent medical staff. According to them, the patient was treated with the utmost care, caution, skill, devotion, and dedication, maintaining that the procedure adopted was in the best interest of the patient.

Previously while considering the matter, the State Commission had directed the hospital and doctor to pay Rs 40 lakh as compensation in lumpsum for the loss of mother, her love, affection, future care, mental agony, harassment etc. to the minor children of the patient and for the mental agony and harassment to the husband of the deceased.

“The opposite parties are directed to comply with this order within a period of two months from the date of receipt of certified copy thereof jointly and severally. The opposite parties are further directed to deposit Rs.15,00,000/- (Rupees fifteen lakh only), each, in the shape of FDRs in a nationalized Bank, in favour of the minor complainants i.e. complainant Nos.2 and 3, which may earn maximum interest and complainants Nos.2 and 3 shall be entitled to withdraw the amount of interest accrued on the said FDRs, from time to time, for their daily pursuits, through their guardian. They shall be entitled to withdraw the entire outstanding amounts of the FDRs, when they will attain the age of 21 years. The rest of the amount of Rs.10,00,000/- shall be paid to complainant No.1 within the above said period of two months,” the State Commission had ordered.

Being aggrieved by the order, the hospital and the doctor approached the NCDRC. They submitted that the portal vein injury is a known albeit rare occurrence during laparoscopic cholecystectomy. They further submitted that it happened during the open part of the procedure and not during the laparoscopic.

The said injury is a common event at the hands of the most experienced surgeons in the field. Just because an unexpected injury during an operation does not make the surgeon automatically negligent, they submitted. Further, they argued that after the injury they took due medical care to the extent that they could by clamping the vein and achieving haemastasis. 

Apart from this, the doctor and the hospital further submitted that there was no delay in referring the patient to PGI Chandigarh and nothing was concealed while referring her. They argued that the fact that the complainants went against the referral of the appellant to PGI Chandigarh shows that a false case had been made up against the appellant.

Examination of the death summary of Fortis Hospital reveals that death was due to failure to repair the portal vein at Fortis Hospital. Thus, making them party to the case amounts to non-impleadment of parties which is fatal to the case. The death summary also shows the history of cardiac arrests at Janak Surgicare which never occurred, they further submitted.

While considering the matter, the top consumer court noted that as per records, to remove the gallbladder, the surgeon frees it from the liver by clipping and cutting the cystic duct and the cystic artery, the main blood supply to the gallbladder. Clipping and cutting of the common bile duct is not part of the procedure and, if not repaired, it will result in serious harm to the patient.

The Apex Consumer Court observed that it is undisputed that the treating surgeon who performed both laparoscopy and open cholecystectomy and the other staff of the hospital assisted him, within the scope and course of their employment.

“Thus, liability, vicariously applies to OP-1. It is the contention of the Complainants that by causing such injury, OPs who owed a duty to conduct a proper and safe surgical procedure with reasonable professional competence and care, failed in that duty and, thereafter failed to take effective and timely steps to control the loss of blood. As a consequence, a person who went to OP-1 hospital to undergo a routine operation such as the present case ended up with losing life the very next day,” observed the NCDRC bench.

The Complainants asserted that while the patient was to undergo a laparoscopic or “laser operation”, he was surprised to know that it was unsuccessful and was converted to open surgery. During the surgery, the patient’s portal vein was cut and started bleeding; the doctor and hospital failed to control the internal bleeding, which resulted in her death within 16 hours.

They argued that the injury to the portal vein was caused negligently and it could have been averted if the hospital and other assisting staff applied proper care, diligence, and skill of a reasonable surgeon.

Taking note of these contentions, the NCDRC bench noted,

“An injury caused and not recognized by the surgeon is regarded as negligence. In the present case, initially it was the duty of the Complainant to prove that the said injury to the deceased was due to negligence in giving her treatment by OPs and that there was a failure on the part of OP doctors and/or other staff to adhere to ordinary level of skill and diligence possessed and exercised by them. While medical professionals are not expected to be of highest possible degree of professional skills always, but they are bound to ensure reasonable skill and care. The maxim ‘res ipsa loquitur’ is used to describe the proof of facts which are sufficient to support an inference that the OPs were negligent and to establish a prima facie case against them. It is not a presumption of law, but a permissible inference, which may be drawn, if upon all the facts, it appears to be justified. It is invoked in the circumstances, when the known facts relating to negligence consists of the occurrence itself or where the occurrence may be of such nature as to warrant an inference of negligence. The maxim alters neither the incidence of onus nor the rules of pleading.”

The Apex consumer court noted that it is undisputed that the said injury was sustained during her admission and the course of surgery at the hospital, she died consequently within a day. 

“The Complainant has been able to discharge the onus of proving on a balance of probabilities, the negligence averred against the OPs. The deceased was of 38 years of age with two children of 15 years and 8 years, at the time of her death,” noted the Consumer Court.

Therefore, upholding the order passed by the State Commission, the NCDRC bench noted,

“It is established that the death of *** who sought medical attention at OP-1 Hospital on 11.06.2014 was operated upon for laparoscopic cholecystectomy on 13.06.2014 and the procedure was performed by OP-2, with assistance from OP-3- Dr. *** Kapoor. During the surgery, she suffered a cut injury to the portal vein resulting in leakage of blood into her abdominal cavity, leading to severe deterioration in her condition. She was rushed to PGI, Chandigarh for vascular repair. In transit, her condition worsened, prompting a decision to admit her to Fortis Hospital, Mohali where a vascular surgeon performed surgery to rectify the portal vein injury. Due to delay in vascular repair and significant blood loss she died on 14.06.2014. Had the surgery cholecystectomy been performed with due care and professional diligence, her portal vein would not have sustained the cut injury. Therefore, the medical negligence on the part of OP-2 and OP-1 hospital staff is substantially established. Further, the learned State Commission duly considered all necessary facts and circumstances of the case as well as the precedents for determining the compensation to be awarded to the Complainants.”

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/janak-surgicare-hospital-234809.pdf

Also Read: Homeopath Poses as Gynaecologist, prescribes allopathic medicines: Consumer Court Slaps Rs 30 Lakh Compensation for medical negligence

Powered by WPeMatico

Indian System of Medicine not Getting Audience Internationally for Want of Adequate Research: Madras HC

Madurai: Emphasizing the need for research in the field of the Indian System of Medicine, the Madras High Court bench recently observed that due to the failure to conduct any clinical trial and adequate research, this medicinal system is not getting the required audience internationally.

“The fact remains that even after 75 years of independence, we have not conducted any clinical trial and got recognized / approved in this system of medicine. For want of adequate research, our system of Medicine is not getting required audience at the international level,” observed the Madurai bench of the High Court further adding that “The development of Indian System of Medicine would not only benefit the mankind, but also take the pride of this country to the entire world.”

These observations were made by the HC bench comprising Justices SS Sundar and B Pugalendhi while considering a plea by the Tamil Nadu Government praying to the court to lift the prohibition order allowing the demolition of the old Government Siddha Medical College at Palayamkottai. The State Government proposed setting up a University for the Indian System of Medicine in Chennai.

Although the HC bench praised the State for its attempts to introduce Tamil Nadu Siddha Medical University Act 2022 it further suggested the State to reconsider its decision to set up the new University in Chennai.

“…while lauding the Government for having initiated steps to bring-in a legislature, viz., Tamil Nadu Siddha Medical University Act, 2022, which is now said to be pending with the Hon’ble Governor for his assent, we request the Government to reconsider the decision of establishing the Siddha University near Chennai and shall find a suitable place near the Western Ghats where this system actually blossomed and where it can reach its glory. The development of Indian System of Medicine would not only benefit the mankind, but also take the pride of this country to the entire world,” observed the bench.

“Even during the British period, the Indian System of Medicine, including Siddha, was recognized as a medicine in the Government Indian Medical School, which was established in the year 1924. Unfortunately, there is no proper patronage after independence. The first College for Siddha was established in the year 1956 at Courtallam on the Western Ghats, realizing the importance of a college for Siddha only on such places like Courtrallam or Pothigaimalai. However, now the policy decision has been taken to establish the University near Chennai, in a 30 acres of land,” it further noted.

The Government Siddha Medical College at Palayamkottai is the first of its kind in Siddha medicine in India. Although originally the college was functioning at Courtallam, it was later shifted to Palayamkottai in November 1964 as a temporary measure. 

However, the temporary campus did not have the required land as per the Indian Medicine Central Council Act. Further, the college also lacked proper infrastructure including an herbal garden, playground, and auditorium for the Students. This resulted in an agitation by the students demanding the necessary infrastructure.

The agitation of the students drew the Government’s attention and the State assured that necessary infrastructure would be made available to them. Therefore, the State mooted the proposal to set up a separate University for Siddha and other systems of Indian Medicine.

Back in 2014, during the Golden Jubilee Year of the institute, the State proposed to demolish the Pediatric Ward, Green House, Car Shed etc. to set up a Golden Jubilee building. Meanwhile, since no action was taken to construct a separate university, a former student approached the High Court, which in turn directed the State to implement the Government Order for setting up a separate university.

However, without proceeding with the establishment of the University, the State attempted to renovate the existing building at Palayamkottai. Therefore, the same petitioner i.e. the former student of Government Siddha Medical College filed another plea as a Public Interest Litigation for a mandamus forbearing the officials from demolishing the existing building at Government Siddha Medical College, Palayamkottai, till such time they establish a University for Indian Medicine at Chettikulam, Tirunelveli District.

Subsequently, the Court passed an order forbearing the State from demolishing existing buildings. Following this, the State filed the plea before the High Court praying to modify the earlier order and enable the Government to demolish the building.

While considering the matter, the HC bench noted that the college was allowed to continue in the temporary place for the past 60 years for the convenience of the professors and the staff. Further, the bench observed that the present main campus at Palayamkottai is less than 5 acres which is inadequate for a Siddha Medical College. 

“Even during the year 2012, the Central Council for Indian Medicine refused permission to the Government Siddha Medical College, Palayamkottai, on the ground of lack of infrastructure. The Students approached the Principal Seat of this Court and by order dated 12.03.2012, this Court set aside the order of the Central Council of Indian Medicine and saved the institution,” noted the Court.

The bench observed that the State itself has admitted that the space available in the existing campus was very limited, there was no scope for expansion and they cannot comply with the norms laid down by the Central Council of Indian Medicine. 

“When the Government has taken such a stand in the earlier writ petition, we are not able to understand as to why they are keen in spending more amount to the existing campus, which would not fulfill the requirements…Any further spending of money in the existing place would not serve the purpose for which the College was established. This System of Medicine emerged from the Western Ghats and the space originally identified at Courtallam has to be restored by utilizing the funds available for renovating the College,” observed the bench.

Ruling that the existing campus can be used as a Siddha Hospital and the college has to be established in the original place at Courtallam or at the place which was initially identified for Siddha University at Chettikulam, the bench ordered, “Decisions have to be taken in the interest of the Society at large, instead of the convenience of the Professors and Staff and therefore, we are not inclined to modify the earlier order dated 15.12.2020. The existing campus can be used as a Siddha Hospital and the College has to be established in the original place at Courtallam or at the place which was initially identified for Siddha University at Chettikulam, which meets the present norm requirements and also have sufficient scope for future expansion as well.”

Regarding the State’s proposal for setting up the University in Chennai, the bench noted, “We feel that the projects are often taken to Chennai for the convenience of the Administrators, rather than the requirements of the projects. Siddha medicine is basically of herbs, which would be available in plenty in forests. Not only the College, the University also requires a proper infrastructure of sufficient land space with a garden of medicinal plants and sufficient space for research facilities. By providing proper infrastructure alone, the required object can be achieved.”

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/madras-hc-indian-system-of-medicine-234932.pdf

Also Read: Ayurveda doctors not entitled to equal pay as allopathy doctors: SC junks appeal seeking withdrawal of earlier order

Powered by WPeMatico

Paxlovid more effective than molnupiravir in protecting against all-cause mortality in severe COVID-19 in adults: Study

In a recent comprehensive study in Hong Kong, researchers investigated the effectiveness of oral antivirals and vaccinations in mitigating mortality and severe COVID-19 progression among hospitalized adults with confirmed SARS-CoV-2 infection. The study aimed to provide insights into the efficacy of these interventions in improving patient outcomes and informing public health strategies amidst the ongoing COVID-19 pandemic. As the COVID-19 pandemic continues to pose significant challenges globally, understanding the efficacy of different interventions is crucial for optimizing patient outcomes and public health strategies.

This study was published in the International Society for Infectious Diseases by Yue Yat and colleagues. The study focused on hospitalized adult patients aged 18 or above who tested positive for SARS-CoV-2 between March 16th, 2022, and December 31st, 2022, in Hong Kong. To address potential biases, researchers employed an inverse probability weighted (IPW) Andersen-Gill model with time-dependent predictors. This analytical approach allowed for the estimation of causal effects associated with oral antivirals and vaccinations in preventing severe COVID-19 outcomes.

The key findings of the study were:

  • Analysis of the data revealed noteworthy findings regarding the effectiveness of oral antivirals and vaccinations in reducing mortality and severe COVID-19 progression.

  • When administered within five days of confirmed infection, nirmatrelvir–ritonavir demonstrated superior efficacy compared to molnupiravir in protecting against all-cause mortality and severe COVID-19 development.

  • The study found no significant difference in the effectiveness of the CoronaVac and Comirnaty vaccines in reducing mortality and severe COVID-19 progression.

Recent research from Hong Kong suggests that oral antivirals and vaccinations can significantly lower the risk of progression to severe COVID-19 among hospitalized patients with confirmed SARS-CoV-2 infection. Specifically, nirmatrelvir–ritonavir demonstrated superior effectiveness in providing protection compared to molnupiravir. Furthermore, the study found no significant difference in effectiveness between CoronaVac and Comirnaty vaccines. Additionally, causal inference techniques were employed to mitigate self-selection bias associated with vaccination choice.

The study’s findings emphasize the importance of timely intervention with oral antivirals and vaccinations in mitigating the risks associated with severe COVID-19 outcomes among hospitalized patients. By providing valuable insights into the efficacy of different interventions, this research contributes to the ongoing efforts to optimize COVID-19 treatment and prevention strategies. Moving forward, continued research and implementation of evidence-based interventions are essential for reducing the burden of COVID-19 and safeguarding public health.

Reference:

Cheung, Y. Y. H., Lau, E. H. Y., Yin, G., Lin, Y., Jiang, J., Cowling, B. J., & Lam, K. F. (2024). Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 107012, 107012. https://doi.org/10.1016/j.ijid.2024.107012

Powered by WPeMatico

What’s the difference between autism and Asperger’s disorder?

Swedish climate activist Greta Thunberg describes herself as having Asperger’s while others on the autism spectrum, such as Australian comedian Hannah Gatsby, describe themselves as “autistic”. But what’s the difference?

Powered by WPeMatico

How safe are your solar eclipse glasses? Cheap fakes from online marketplaces pose a threat, supply-chain experts say

Americans from Maine to Texas are set for a rare treat on April 8, 2024, when a total solar eclipse will be visible across much of the U.S.

Powered by WPeMatico

CARv3-TEAM-E T-cell treatment beneficial for recurrent glioblastoma

For patients with recurrent glioblastoma, treatment with chimeric antigen receptor (CAR) T-cells engineered to target the epidermal growth factor receptor (EGFR) variant III tumor-specific antigen, in addition to the wild-type EGFR protein, through secretion of a T-cell-engaging antibody molecule (TEAM; CARv3-TEAM-E) results in radiographic tumor regression, according to a study published online March 13 in the New England Journal of Medicine.

Powered by WPeMatico

Positive causal link ID’d between computer use, erectile dysfunction

A higher genetic susceptibility to leisure computer usage is associated with an increased risk for erectile dysfunction (ED), according to a study published in Andrology.

Powered by WPeMatico

Treatments tailored to you: How AI will change NZ health care, and what we have to get right first

Imagine this: a novel virus is rapidly breaking out nationwide, resulting in an epidemic. The government introduces vaccination mandates and a choice of different vaccines is available.

Powered by WPeMatico